Central nervous system-mediated suppression of hepatic glucose production via GLP-1 circuits is noted in murine studies, but less certain in humans [27]
Some patients may respond more favorably to semaglutide or struggle with tirzepatides side effects
Fourth, despite the high quality of RCTs, patients typically enrolled in RCTs are highly selected and may not be representative of the general T2DM or obese population, possibly limiting the external validation of these findings
Pathogenesis Arises from terminal ductule epithelial cells (canal of Hering cells) spontaneously, following liver infections, and secondary to hepatotoxic injury
PlexusDx Precision Peptide Genetic Test ($99 add-on after first month) maps 14 peptide pathways and identifies variants like GLP1R rs6923761 that influence your semaglutide response
IDF Diabetes Atlas: Global Estimates of the Prevalence of Diabetes for 2011 and 2030